Chandra, Vikash http://orcid.org/0000-0002-2713-1831
Ibrahim, Hazem http://orcid.org/0000-0003-0165-2660
Halliez, Clémentine http://orcid.org/0000-0002-5683-515X
Prasad, Rashmi B. http://orcid.org/0000-0002-4400-6741
Vecchio, Federica
Dwivedi, Om Prakash http://orcid.org/0000-0001-8670-7717
Kvist, Jouni http://orcid.org/0000-0002-4089-8877
Balboa, Diego http://orcid.org/0000-0002-4784-5452
Saarimäki-Vire, Jonna http://orcid.org/0000-0002-8865-7060
Montaser, Hossam
Barsby, Tom
Lithovius, Väinö
Artner, Isabella http://orcid.org/0000-0002-2895-5664
Gopalakrishnan, Swetha
Groop, Leif http://orcid.org/0000-0002-0187-3263
Mallone, Roberto http://orcid.org/0000-0002-9846-8861
Eizirik, Decio L.
Otonkoski, Timo http://orcid.org/0000-0001-9190-2496
Funding for this research was provided by:
Academy of Finland (312437)
Novo Nordisk Fonden (2019-2022)
Sigrid Juséliuksen Säätiö (2018-2021)
Article History
Received: 10 March 2022
Accepted: 13 October 2022
First Online: 26 October 2022
Competing interests
: D.L.E. received grant support from Eli Lilly and Company, Indianapolis, for research on new approaches to protect pancreatic beta cells in T1D. The remaining authors declare no competing interests.